Pfizer said that Corey Goodman, a senior vice president hired 19 months ago to lead Pfizer’s biotechnology center in California, has resigned.
Pfizer gave no reason for Goodman’s departure in a filing with the U.S. Securities and Exchange Commission today. Goodman held the title of president of Pfizer’s Biotherapeutics and Bioinnovation Center in South San Francisco, California. His resignation is effective May 31.
2 comments:
Not too surprising, Goodman was probably collateral damage from the Wyeth acquisition. By now everyone should realize that you cannot trust big pharma- they have lost all credibility. I am sure you will not hear a peep from Goodman, he more than likely signed away any rights to receive a nice hefty severance check.
He's now chairman of a new stem cell (merger of two) company iPierian
http://www.fiercebiotech.com/story/promising-stem-cell-start-ups-merge-add-11-5m/2009-07-08?utm_medium=nl&utm_source=internal
Post a Comment